Latest Headlines

  1. Clinical Genomics Announces Nationwide Expansion Of Patient Access To COLVERA® 1/11/2021

    Clinical Genomics (“CG” or the “Company”), a provider of cancer diagnostic solutions, including liquid biopsy tests, today announced that the New York State Department of Health (“NYSDOH”) has issued a permit to enable New York patients to access COLVERA, the Company’s liquid biopsy test designed to detect residual and recurrent disease in colorectal cancer (“CRC”). COLVERA now has availability to all 50 states

  2. Abbott Receives FDA 510(k) Clearance For The First Rapid Handheld Blood Test For Concussions 1/11/2021

    Abbott (NYSE: ABT) has received 510(k) clearance for the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions. The test will run on Abbott's handheld i-STAT™ Alinity™ platform. Tests results are available within 15 minutes after plasma is placed in the test cartridge

  3. Diagenode Launches Innovative Solution For Small RNA-Sequencing Compatible With MGI’s DNBSE™ Equencers 1/7/2021

    Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has launched a new small RNA-sequencing solution, D-Plex Small RNA DNBSEQ™ Kit , optimized and specifically formatted for MGI’s DNBSEQ sequencers.

  4. Vial Sampling Kits For PFAS Analysis 1/6/2021

    Finneran Porvair has introduced new Convenience Kits for Per- and Polyfluoroalkyl substances (PFAS) testing.

  5. Biotech Team Develops ELISA Protocol For COVID-19 IgG Antibody Detection 1/6/2021

    ZTA Biotech, a Budapest-based biotech startup has announced the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA protocol. This new detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease.

  6. 3DR Labs, An Accumen Company, Announces icometrix Partnership To Bring icobrain Technology To Hospitals And Health Systems Nationally 1/6/2021

    Accumen is helping healthcare get better, faster. Today, Accumen announced a new partnership with icometrix, which will allow it to provide hospitals and health systems nationally with access to the AI-based icobrain software

  7. High-Quality SARS-CoV-2 Antigen Protein Kits 1/5/2021

    AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.

  8. New Certified COVID-19 Testing Lab Opens At Kean 1/5/2021

    A new federally certified campus lab that will process COVID-19 test results opened at Kean University today, building upon an unprecedented partnership with the County of Union in diagnostic testing and critical public health research during the pandemic.

  9. Biocare Medical Unveils ONCORE Pro, A Fully Automated IVD Benchtop Platform For Immunohistochemistry And In-Situ Hybridization 1/5/2021

    Biocare Medical, LLC, a leading provider of innovative immunohistochemistry (IHC) instrumentation and reagents, announces the release of the fully automated staining platform ONCORE Pro™ for IHC and ISH applications

  10. Hologic To Acquire Biotheranostics, Leader In Molecular Tests For Breast And Metastatic Cancers, For Approximately $230M 1/5/2021

    Hologic, Inc., a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230M, subject to working capital and other customary closing adjustments